How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post-MI Study.
Leonardo De LucaFurio ColivicchiJennifer MeessenMassimo UguccioniFederico PiscionePaola BernabòGerardina LardieriAntonino GranatelliDomenico GabrielliMichele M Gulizianull nullPublished in: Clinical cardiology (2019)
Risk scores recommended by current guidelines for guiding decisions on DAPT duration are underused and misused in clinical practice. A PCI with multiple stents and a history of PAD resulted as the clinical variables more frequently associated with DAPT continuation beyond 1 year from the index MI.
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- acute coronary syndrome
- clinical practice
- end stage renal disease
- newly diagnosed
- ejection fraction
- acute myocardial infarction
- heart failure
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- coronary artery disease
- chronic kidney disease
- peritoneal dialysis
- atrial fibrillation
- patient reported outcomes
- breast cancer risk